TY  - JOUR
AU  - Ruiz, E Josue
AU  - Diefenbacher, Markus E
AU  - Nelson, Jessica K
AU  - Sancho, Rocio
AU  - Pucci, Fabio
AU  - Chakraborty, Atanu
AU  - Moreno, Paula
AU  - Annibaldi, Alessandro
AU  - Liccardi, Gianmaria
AU  - Encheva, Vesela
AU  - Mitter, Richard
AU  - Rosenfeldt, Mathias
AU  - Snijders, Ambrosius P
AU  - Meier, Pascal
AU  - Calzado, Marco A
AU  - Behrens, Axel
PY  - 2018
DO  - 10.1084/jem.20180742
UR  - http://hdl.handle.net/10668/13422
T2  - The Journal of experimental medicine
AB  - Lung squamous cell carcinoma (LSCC) and adenocarcinoma (LADC) are the most common lung cancer subtypes. Molecular targeted treatments have improved LADC patient survival but are largely ineffective in LSCC. The tumor suppressor FBW7 is commonly...
LA  - en
PB  - Rockefeller University Press
KW  - Adenocarcinoma of lung
KW  - Animals
KW  - Carcinoma, squamous cell
KW  - Cisplatin
KW  - Drug resistance, neoplasm
KW  - Humans
KW  - Lung neoplasms
KW  - Mice
KW  - Multienzyme complexes
KW  - Proto-oncogene proteins p21(ras)
KW  - Ubiquitination
TI  - LUBAC determines chemotherapy resistance in squamous cell lung cancer.
TY  - Research article
VL  - 216
ER  -